您当前的位置:
Acetyl-L-carnitine (Synonyms:L-乙酰基肉碱;O-Acetyl-L-carnitine; ALCAR)
目录号 : KM32534 CAS No. : 3040-38-8 纯度 : 99%

Acetyl-L-carnitine (O-Acetyl-L-carnitine; ALCAR) 是一种口服有效的线粒体能量代谢调节剂及神经保护剂,可透过血脑屏障。Acetyl-L-carnitine 通过有机阳离子转运体 OCTN2 选择性进入细胞及大脑。Acetyl-L-carnitine 可作为乙酰供体参与脂肪酸 β-氧化、促进乙酰胆碱合成、调节线粒体功能及抑制氧化应激。Acetyl-L-carnitine 通过提升能量代谢、保护神经元和改善突触可塑性发挥活性。Acetyl-L-carnitine 主要用于新生儿缺氧缺血性脑损伤、阿尔茨海默病、抑郁症等神经退行性疾病及代谢紊乱相关疾病的研究。

规格 价格 是否有货 数量
10mg
In-stock
25mg
In-stock
50mg
In-stock
100mg
In-stock
500mg
In-stock
10 mM * 1 mL in DMSO
In-stock

Other Forms of Rapamycin:

KKL Med 的所有产品和服务仅用于科学研究,不能被用于人体,兽医,我们也不向个人提供产品和服务。
生物活性

Acetyl-L-carnitine (O-Acetyl-L-carnitine; ALCAR) is an orally active mitochondrial energy metabolism regulator and neuroprotectant that can penetrate the blood-brain barrier. Acetyl-L-carnitine selectively enters cells and the brain through the organic cation transporter OCTN2. Acetyl-L-carnitine can participate in fatty acid β-oxidation, promote acetylcholine synthesis, regulate mitochondrial function and inhibit oxidative stress as an acetyl donor. Acetyl-L-carnitine exerts its activity by enhancing energy metabolism, protecting neurons and improving synaptic plasticity. Acetyl-L-carnitine is mainly used in the study of neurodegenerative diseases and metabolic disorder-related diseases such as neonatal hypoxic-ischemic brain damage, Alzheimer's disease, and depression.

IC50&Target
Human Endogenous Metabolite
体外研究

Cell viability and apoptosis:
Acetyl-L-carnitine (1 mM; 30 min) significantly inhibited caspase-3/9 activation induced by 1 μ g/mL Doxycycline in DT40 cells with thioredoxin TRX2 deficiency, reduced reactive oxygen species (ROS) production and cell apoptosis, and maintained cysteine levels [1].

 

Cell Viability Assay

Cell Line: TRX2-/- DT40 cells (chicken B-cell line)
Concentration: 1 mM
Incubation Time: 30 min pretreatment before 1 μg/mL Doxycycline induction
Result:

Reduced activation of caspase-3 and caspase-9, key markers of mitochondrial apoptosis pathway, compared to untreated cells.

Decrease 40% in intracellular ROS levels, indicating attenuation of oxidative stress.

Maintained glutathione levels in both cytosol and mitochondria, preventing redox imbalance caused by TRX2 deficiency.

Resulted 35% reduction in apoptotic cell population, confirming protective effects against mitochondrial-dependent apoptosis.

体内研究

Acetyl-L-carnitine (100 mg/kg; intraperitoneal injection; Every time; 14 days) significantly reduced brain damage in the neonatal hypoxic-ischemic brain injury (HIBD) model, improved neurological function, lowered oxidative stress levels, and reduced cell apoptosis [2].
Acetyl-L-carnitine (300 mg/kg; oral gavage; Every time; 28 days) Improve the cognitive function of the elderly cognitive impairment model, enhance synaptic plasticity in the hippocampus, and increase the expression of brain-derived neurotrophic factor (BDNF).

 

Animal Model: Neonatal Sprague-Dawley rats (male, 18-22g, postnatal day 7), hypoxic-ischemic brain damage (HIBD) model[2]
Dosage: 100 mg/kg
Administration: Intraperitoneal injection, once daily, for 14 consecutive days starting 24 hours after HIBD induction
Result:

Brain injury: Reduced infarct volume by 40% compared to the HIBD control group as measured by triphenyltetrazolium chloride (TTC) staining.

Neurological function: Improved neurological scores, including motor function, sensory function, and balance, as evaluated by a modified neurological severity score (mNSS).

 
分子式
C9H17NO4
分子量
203.24
CAS号
3040-38-8
中文名称
L-乙酰基肉碱;乙酰左卡尼汀
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

2-8°C,  keep dry and cool

* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

溶解性数据
In Vitro:

H2O : 100 mg/mL (492.03 mM; Need ultrasonic)

DMSO : 14.29 mg/mL (70.31 mM; ultrasonic and warming and heat to 60°C)

配制储备液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 4.9203 mL 24.6015 mL 49.2029 mL
5 mM 0.9841 mL 4.9203 mL 9.8406 mL
10 mM 0.4920 mL 2.4601 mL 4.9203 mL
*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month。-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。

In Vivo:

请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂:

——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;以下溶剂前显示的百
分比是指该溶剂在您配制终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶

  • 1.

    请依序添加每种溶剂: 10% DMSO → 40% PEG300 → 5% Tween-80 → 45% saline

    Solubility: ≥ 2.5 mg/mL (12.30 mM); Clear solution

    此方案可获得 ≥ 2.5 mg/mL (12.30 mM,饱和度未知) 的澄清溶液。

    以 1 mL 工作液为例,取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中,混合均匀;向上述体系中加入50 μL Tween-80,混合均匀;然后继续加入 450 μL生理盐水定容至 1 mL。

  • 2.

    请依序添加每种溶剂: 10% DMSO → 90% (20% SBE-β-CD in saline)

    Solubility: ≥ 2.5 mg/mL (12.30 mM); Clear solution

    此方案可获得 ≥ 2.5 mg/mL (12.30 mM,饱和度未知) 的澄清溶液。

    以 1 mL 工作液为例,取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 900 μL 20% 的 SBE-β-CD 生理盐水水溶液中,混合均匀。

  • 3.

    请依序添加每种溶剂: 10% DMSO → 90% corn oil

    Solubility: ≥ 2.5 mg/mL (12.30 mM); Clear solution

    此方案可获得 ≥ 2.5 mg/mL (12.30 mM,饱和度未知) 的澄清溶液,此方案不适用于实验周期在半个月以上的实验。

    以 1 mL 工作液为例,取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 900 μL玉米油中,混合均匀。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2
动物实验计算换算器
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系客服为您提供正确的澄清溶液配方)
+
+
+

计算结果:

工作液浓度 mg/ml;

DMSO母液配制方法 mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,

体内配方配制方法μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL ddH2O,混匀澄清。

配置后的溶液总体积

1. 首先保证母液是澄清的;
           2. 一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。